# Tesla, Inc.: financial statements, quarterly

TSLA · Nasdaq · CIK 1318605 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tsla.md) · [Financials](/companies/tsla/financials.md) · [Filings](/companies/tsla/filings.md) · [Insiders](/companies/tsla/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tsla/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [25.2 d](/filings/0001628280-26-003952.md) | [21.3](/filings/0001628280-25-018911.md) | [25.5](/filings/0001628280-25-035806.md) | [25.2](/filings/0001628280-25-045968.md) | [25.7 d](/filings/0001628280-26-003952.md) | [19.3](/filings/0001628280-26-026673.md) | [22.5](/filings/0001628280-26-049270.md) | [28.1](/filings/0001628280-26-066775.md) | [24.9 d](/filings/0001628280-26-003952.md) | [22.4](/filings/0001628280-26-026673.md) | [28.2](/filings/0001628280-26-049270.md) | [28.0](/filings/0001628280-26-066775.md) |
| Cost of revenue | $bn | [20.7 d](/filings/0001628280-26-003952.md) | [17.6](/filings/0001628280-25-018911.md) | [20.9](/filings/0001628280-25-035806.md) | [20.2](/filings/0001628280-25-045968.md) | [21.5 d](/filings/0001628280-26-003952.md) | [16.2](/filings/0001628280-26-026673.md) | [18.6](/filings/0001628280-26-049270.md) | [23.0](/filings/0001628280-26-066775.md) | [19.9 d](/filings/0001628280-26-003952.md) | [17.7](/filings/0001628280-26-026673.md) | [23.5](/filings/0001628280-26-049270.md) | [22.6](/filings/0001628280-26-066775.md) |
| Gross profit | $bn | [4.4 d](/filings/0001628280-26-003952.md) | [3.7](/filings/0001628280-25-018911.md) | [4.6](/filings/0001628280-25-035806.md) | [5.0](/filings/0001628280-25-045968.md) | [4.2 d](/filings/0001628280-26-003952.md) | [3.2](/filings/0001628280-26-026673.md) | [3.9](/filings/0001628280-26-049270.md) | [5.1](/filings/0001628280-26-066775.md) | [5.0 d](/filings/0001628280-26-003952.md) | [4.7](/filings/0001628280-26-026673.md) | [4.8](/filings/0001628280-26-049270.md) | [5.5](/filings/0001628280-26-066775.md) |
| Research and development | $bn | [1.1 d](/filings/0001628280-26-003952.md) | [1.2](/filings/0001628280-25-018911.md) | [1.1](/filings/0001628280-25-035806.md) | [1.0](/filings/0001628280-25-045968.md) | [1.3 d](/filings/0001628280-26-003952.md) | [1.4](/filings/0001628280-26-026673.md) | [1.6](/filings/0001628280-26-049270.md) | [1.6](/filings/0001628280-26-066775.md) | [1.8 d](/filings/0001628280-26-003952.md) | [1.9](/filings/0001628280-26-026673.md) | [2.4](/filings/0001628280-26-049270.md) | [2.8](/filings/0001628280-26-066775.md) |
| Selling, general and administrative | $bn | [1.3 d](/filings/0001628280-26-003952.md) | [1.4](/filings/0001628280-25-018911.md) | [1.3](/filings/0001628280-25-035806.md) | [1.2](/filings/0001628280-25-045968.md) | [1.3 d](/filings/0001628280-26-003952.md) | [1.3](/filings/0001628280-26-026673.md) | [1.4](/filings/0001628280-26-049270.md) | [1.6](/filings/0001628280-26-066775.md) | [1.7 d](/filings/0001628280-26-003952.md) | [1.8](/filings/0001628280-26-026673.md) | [2.0](/filings/0001628280-26-049270.md) | [2.0](/filings/0001628280-26-066775.md) |
| Operating income | $bn | [2.1 d](/filings/0001628280-26-003952.md) | [1.2](/filings/0001628280-25-018911.md) | [1.6](/filings/0001628280-25-035806.md) | [2.7](/filings/0001628280-25-045968.md) | [1.6 d](/filings/0001628280-26-003952.md) | [0.4](/filings/0001628280-26-026673.md) | [0.9](/filings/0001628280-26-049270.md) | [1.6](/filings/0001628280-26-066775.md) | [1.4 d](/filings/0001628280-26-003952.md) | [0.9](/filings/0001628280-26-026673.md) | [0.4](/filings/0001628280-26-049270.md) | [0.7](/filings/0001628280-26-066775.md) |
| Interest expense | $bn | [0.1 d](/filings/0001628280-24-002390.md) | [0.1](/filings/0001628280-24-017503.md) | [0.1](/filings/0001628280-24-032662.md) | [0.1](/filings/0001628280-25-045968.md) | [0.1 d](/filings/0001628280-26-003952.md) | [0.1](/filings/0001628280-26-026673.md) | [0.1](/filings/0001628280-26-049270.md) | [0.1](/filings/0001628280-26-066775.md) | [0.1 d](/filings/0001628280-26-003952.md) | [0.1](/filings/0001628280-26-026673.md) | [0.1](/filings/0001628280-26-049270.md) | [0.1](/filings/0001628280-26-066775.md) |
| Income tax | $bn | [(5.8) d](/filings/0001628280-26-003952.md) | [0.5](/filings/0001628280-25-018911.md) | [0.4](/filings/0001628280-25-035806.md) | [0.6](/filings/0001628280-25-045968.md) | [0.4 d](/filings/0001628280-26-003952.md) | [0.2](/filings/0001628280-26-026673.md) | [0.4](/filings/0001628280-26-049270.md) | [0.6](/filings/0001628280-26-066775.md) | [0.3 d](/filings/0001628280-26-003952.md) | [0.3](/filings/0001628280-26-026673.md) | [0.2](/filings/0001628280-26-049270.md) | [0.2](/filings/0001628280-26-066775.md) |
| Net income | $bn | [7.9 d](/filings/0001628280-26-003952.md) | [1.4](/filings/0001628280-25-018911.md) | [1.4](/filings/0001628280-25-035806.md) | [2.2](/filings/0001628280-25-045968.md) | [2.1 d](/filings/0001628280-26-003952.md) | [0.4](/filings/0001628280-26-026673.md) | [1.2](/filings/0001628280-26-049270.md) | [1.4](/filings/0001628280-26-066775.md) | [0.8 d](/filings/0001628280-26-003952.md) | [0.5](/filings/0001628280-26-026673.md) | [1.1](/filings/0001628280-26-049270.md) | [0.8](/filings/0001628280-26-066775.md) |
| Diluted EPS | $ per share | not reported | [0.41](/filings/0001628280-25-018911.md) | [0.40](/filings/0001628280-25-035806.md) | [0.62](/filings/0001628280-25-045968.md) | not reported | [0.12](/filings/0001628280-26-026673.md) | [0.33](/filings/0001628280-26-049270.md) | [0.39](/filings/0001628280-26-066775.md) | not reported | [0.13](/filings/0001628280-26-026673.md) | [0.32](/filings/0001628280-26-049270.md) | [0.22](/filings/0001628280-26-066775.md) |
| Basic EPS | $ per share | not reported | [0.45](/filings/0001628280-25-018911.md) | [0.44](/filings/0001628280-25-035806.md) | [0.68](/filings/0001628280-25-045968.md) | not reported | [0.13](/filings/0001628280-26-026673.md) | [0.36](/filings/0001628280-26-049270.md) | [0.43](/filings/0001628280-26-066775.md) | not reported | [0.15](/filings/0001628280-26-026673.md) | [0.34](/filings/0001628280-26-049270.md) | [0.24](/filings/0001628280-26-066775.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [16.4](/filings/0001628280-26-003952.md) | [11.8](/filings/0001628280-25-018911.md) | [14.6](/filings/0001628280-25-035806.md) | [18.1](/filings/0001628280-25-045968.md) | [16.1](/filings/0001628280-26-066775.md) | [16.4](/filings/0001628280-26-026673.md) | [15.6](/filings/0001628280-26-049270.md) | [18.3](/filings/0001628280-26-066775.md) | [16.5](/filings/0001628280-26-066775.md) | [16.6](/filings/0001628280-26-026673.md) | [15.2](/filings/0001628280-26-049270.md) | [17.9](/filings/0001628280-26-066775.md) |
| Current assets | $bn | [49.6](/filings/0001628280-25-003063.md) | [50.5](/filings/0001628280-24-017503.md) | [53.0](/filings/0001628280-24-032662.md) | [56.4](/filings/0001628280-24-043486.md) | [58.4](/filings/0001628280-26-003952.md) | [59.4](/filings/0001628280-25-018911.md) | [61.1](/filings/0001628280-25-035806.md) | [64.7](/filings/0001628280-25-045968.md) | [68.6](/filings/0001628280-26-066775.md) | [69.7](/filings/0001628280-26-026673.md) | [68.8](/filings/0001628280-26-049270.md) | [70.4](/filings/0001628280-26-066775.md) |
| Total assets | $bn | [107](/filings/0001628280-25-003063.md) | [109](/filings/0001628280-24-017503.md) | [113](/filings/0001628280-24-032662.md) | [120](/filings/0001628280-24-043486.md) | [122](/filings/0001628280-26-003952.md) | [125](/filings/0001628280-25-018911.md) | [129](/filings/0001628280-25-035806.md) | [134](/filings/0001628280-25-045968.md) | [138](/filings/0001628280-26-066775.md) | [144](/filings/0001628280-26-026673.md) | [149](/filings/0001628280-26-049270.md) | [158](/filings/0001628280-26-066775.md) |
| Current liabilities | $bn | [28.7](/filings/0001628280-25-003063.md) | [29.5](/filings/0001628280-24-017503.md) | [27.7](/filings/0001628280-24-032662.md) | [30.6](/filings/0001628280-24-043486.md) | [28.8](/filings/0001628280-26-003952.md) | [29.8](/filings/0001628280-25-018911.md) | [30.0](/filings/0001628280-25-035806.md) | [31.3](/filings/0001628280-25-045968.md) | [31.7](/filings/0001628280-26-066775.md) | [34.1](/filings/0001628280-26-026673.md) | [35.4](/filings/0001628280-26-049270.md) | [40.5](/filings/0001628280-26-066775.md) |
| Total liabilities | $bn | [43.0](/filings/0001628280-25-003063.md) | [44.0](/filings/0001628280-24-017503.md) | [45.6](/filings/0001628280-24-032662.md) | [49.1](/filings/0001628280-24-043486.md) | [48.4](/filings/0001628280-26-003952.md) | [49.7](/filings/0001628280-25-018911.md) | [50.5](/filings/0001628280-25-035806.md) | [53.0](/filings/0001628280-25-045968.md) | [54.9](/filings/0001628280-26-066775.md) | [58.9](/filings/0001628280-26-026673.md) | [61.0](/filings/0001628280-26-049270.md) | [67.6](/filings/0001628280-26-066775.md) |
| Long-term debt | $bn | [2.7](/filings/0001628280-25-003063.md) | [2.7](/filings/0001628280-24-017503.md) | [5.3](/filings/0001628280-24-032662.md) | [5.3](/filings/0001628280-24-043486.md) | [5.5](/filings/0001628280-26-003952.md) | [5.1](/filings/0001628280-25-018911.md) | [5.0](/filings/0001628280-25-035806.md) | [5.6](/filings/0001628280-25-045968.md) | [6.6](/filings/0001628280-26-066775.md) | [7.6](/filings/0001628280-26-026673.md) | [7.7](/filings/0001628280-26-049270.md) | [8.0](/filings/0001628280-26-066775.md) |
| Current portion of debt | $bn | [2.0](/filings/0001628280-25-003063.md) | [2.1](/filings/0001628280-24-017503.md) | [2.0](/filings/0001628280-24-032662.md) | [2.1](/filings/0001628280-24-043486.md) | [2.3](/filings/0001628280-26-003952.md) | [2.2](/filings/0001628280-25-018911.md) | [2.0](/filings/0001628280-25-035806.md) | [1.9](/filings/0001628280-25-045968.md) | [1.6](/filings/0001628280-26-066775.md) | [1.4](/filings/0001628280-26-026673.md) | [1.3](/filings/0001628280-26-049270.md) | [1.3](/filings/0001628280-26-066775.md) |
| Shareholders' equity | $bn | [62.6](/filings/0001628280-25-003063.md) | [64.4](/filings/0001628280-24-017503.md) | [66.5](/filings/0001628280-24-032662.md) | [69.9](/filings/0001628280-24-043486.md) | [72.9](/filings/0001628280-26-003952.md) | [74.7](/filings/0001628280-25-018911.md) | [77.3](/filings/0001628280-25-035806.md) | [80.0](/filings/0001628280-25-045968.md) | [82.1](/filings/0001628280-26-066775.md) | [84.1](/filings/0001628280-26-026673.md) | [86.9](/filings/0001628280-26-049270.md) | [89.3](/filings/0001628280-26-066775.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4,370 d](/filings/0001628280-26-003952.md) | [242](/filings/0001628280-25-018911.md) | [3,612 d](/filings/0001628280-25-035806.md) | [6,255 d](/filings/0001628280-25-045968.md) | [4,814 d](/filings/0001628280-26-003952.md) | [2,156](/filings/0001628280-26-026673.md) | [2,540 d](/filings/0001628280-26-049270.md) | [6,238 d](/filings/0001628280-26-066775.md) | [3,813 d](/filings/0001628280-26-003952.md) | [3,937](/filings/0001628280-26-026673.md) | [4,697 d](/filings/0001628280-26-049270.md) | [6,263 d](/filings/0001628280-26-066775.md) |
| Capital expenditure | $m | [2,307 d](/filings/0001628280-26-003952.md) | [2,777](/filings/0001628280-25-018911.md) | [2,272 d](/filings/0001628280-25-035806.md) | [3,513 d](/filings/0001628280-25-045968.md) | [2,780 d](/filings/0001628280-26-003952.md) | [1,492](/filings/0001628280-26-026673.md) | [2,394 d](/filings/0001628280-26-049270.md) | [2,248 d](/filings/0001628280-26-066775.md) | [2,393 d](/filings/0001628280-26-003952.md) | [2,493](/filings/0001628280-26-026673.md) | [5,789 d](/filings/0001628280-26-049270.md) | [4,732 d](/filings/0001628280-26-066775.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3,468](/filings/0001628280-24-017503.md) | [3,478](/filings/0001628280-24-032662.md) | [3,493](/filings/0001628280-24-043486.md) | [3,484](/filings/0001628280-25-018911.md) | [3,481](/filings/0001628280-25-035806.md) | [3,497](/filings/0001628280-25-045968.md) | [3,521](/filings/0001628280-26-026673.md) | [3,519](/filings/0001628280-26-049270.md) | [3,526](/filings/0001628280-26-066775.md) | [3,538](/filings/0001628280-26-026673.md) | [3,540](/filings/0001628280-26-049270.md) | [3,541](/filings/0001628280-26-066775.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,952,757,946 at 2026-10-15, from the cover of the [10-Q filed 2026-10-22](/filings/0001628280-26-066775.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.